Mercury Biopharmaceutical Corporation (TPEX:6932)
11.15
+0.35 (3.24%)
At close: Dec 5, 2025
-20.07% (1Y)
| Market Cap | 4.67B |
| Revenue (ttm) | 246.00K |
| Net Income (ttm) | -70.59M |
| Shares Out | 418.44M |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 935,927 |
| Average Volume | 1,421,662 |
| Open | 10.80 |
| Previous Close | 10.80 |
| Day's Range | 10.60 - 11.50 |
| 52-Week Range | 4.95 - 17.45 |
| Beta | -2.96 |
| RSI | 69.18 |
| Earnings Date | Nov 14, 2025 |